Across three pan-cancer cohorts, MMRL embeddings consistently achieved higher cross-validated prognostic discrimination than TMB and remained significantly associated with overall survival after adjustment for cancer type and TMB, as well as age where available.
Abstract
Somatic missense mutations are pervasive in cancer genomes, yet existing studies have largely compressed them into mutation burden, mutation signatures, or driver gene annotations. Such representations obscure mutation-specific context and higher-order dependencies, leaving the latent biological structure of somatic mutation landscapes insufficiently characterized by systematic, data-driven approaches. Here we present MMRL, a pan-cancer Missense Mutation Representation Learning framework that learns the representations directly from somatic missense mutation profiles. By integrating mutation-associated features including gene identity, trinucleotide context, AlphaMissense pathogenicity, amino acid substitution and protein positional information, MMRL uses self-supervised learning to capture higher-order patterns among missense mutations across ∼50,000 tumor samples from diverse cancer types. Across three pan-cancer cohorts, MMRL embeddings consistently achieved higher cross-validated prognostic discrimination than TMB and remained significantly associated with overall survival after adjustment for cancer type and TMB, as well as age where available. This prognostic value was also observed among patients treated with immune checkpoint inhibitors. Unsupervised clustering analysis of MMRL embeddings identified nine mutation subtypes in the TCGA pan-cancer cohort, with distinct survival outcomes, cancer-type compositions and mutational signature profiles, indicating that the learned embedding space captured clinically and biologically meaningful structure. Attention-based analyses further indicated that MMRL captured context-dependent mutation patterns beyond mutation frequency and predicted pathogenicity. Together, MMRL provides a data-driven strategy for decoding somatic missense mutation landscape and may facilitate precision oncology.
Cancer genomics has concentrated on individual mutations, overlooking whether somatic mutations can accumulate to produce partial, gene-level disruption with biological and clinical consequences. Sequence-to-function models can quantify these effects directly from DNA sequence. Here, we use AlphaGenome and AlphaMissens...
A. Nayak, Travita Lee, V. Agarwal et al.· medRxiv· 0 citations
This work shows that redundancy among partially overlapping deep mutational scanning experiments, often treated as noise, yields a consensus landscape of mutational constraint, and introduces "variant soundness", an overlap-aware rank-fusion score that uses cross-experiment consistency to derive an assay-agnostic order...
Riccardo Arnese, G. Gambardella· Molecular Systems Biology· 0 citations
Background/Objectives: Mutational signatures reflect the processes that shape cancer genomes. We investigated whether continuous mutational-signature exposures could be inferred from routine histology across tumour types. Methods: We developed whole-slide image regression models for 30 single-base substitution (SBS) si...
Byeong Chang Sim, J. Kim, Jiyeon Park et al.· Cancers· 0 citations
Breast cancer is a heterogeneous disease whose molecular complexity complicates therapeutic stratification. Although PAM50 is a widely used molecular subtyping framework, discrete subtype assignments may underrepresent transitional molecular states and within-subtype heterogeneity relevant to treatment. This study deve...
Al Hanouf Al Khawaldeh, L. Alnemer, Hazem Hiary· BioMedInformatics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.